PB2247: PHARMACOKINETIC MODELING AND SIMULATION TO SUPPORT MITAPIVAT DOSE SELECTION USED IN PEDIATRIC PHASE III STUDIES

por Yin, O., Baron, K., Mondick, J., Little, M., Tyler, P. D., Beynon, V.
Publicado 2022

Animal‐to‐Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule

por Nagy, CF, Mondick, J, Serbina, N, Casey, LS, Carpenter, SE, French, J, Guttendorf, R
Publicado 2016